Carleton Place, ON (pcJ News Briefs) – RockGarden Medicinals Inc., a medical cannabis company, intends to complete a financing of 450,000 common shares, representing 25% of total shareholdings, at $3.40 per share to existing and new shareholders for gross proceeds of $1.53 million.
The financing is expected to close in May 2017.
RockGarden intends to use the proceeds to complete construction on the first of three phases in its staged build plan, as well as to fund general operations.
photo credit: RockGarden Medicinals